2019
DOI: 10.1016/j.bioorg.2019.103299
|View full text |Cite
|
Sign up to set email alerts
|

Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(5 citation statements)
references
References 292 publications
0
5
0
Order By: Relevance
“…This analogy further corroborates previous studies highlighting the tight relationships between antiradical and enzyme inhibition properties [ 33 ]. Considering that these enzymes are key targets in the pharmacotherapy of neurodegenerative diseases, type 2 diabetes, and hyperpigmentation [ 34 , 35 , 36 ], and all characterized by an increased burden of inflammation and oxidative stress, the present data suggest the rationale for testing the P. mahaleb water extract in experimental paradigms simulating these disorders. Furthermore, considering that the observed biological properties of the extract are related, albeit partially, to the presence of phenolic compounds [ 37 , 38 ], a quantitative determination of selected phenols and flavonoids was conducted via HPLC-DAD-MS ( Figure 2 ).…”
Section: Resultsmentioning
confidence: 99%
“…This analogy further corroborates previous studies highlighting the tight relationships between antiradical and enzyme inhibition properties [ 33 ]. Considering that these enzymes are key targets in the pharmacotherapy of neurodegenerative diseases, type 2 diabetes, and hyperpigmentation [ 34 , 35 , 36 ], and all characterized by an increased burden of inflammation and oxidative stress, the present data suggest the rationale for testing the P. mahaleb water extract in experimental paradigms simulating these disorders. Furthermore, considering that the observed biological properties of the extract are related, albeit partially, to the presence of phenolic compounds [ 37 , 38 ], a quantitative determination of selected phenols and flavonoids was conducted via HPLC-DAD-MS ( Figure 2 ).…”
Section: Resultsmentioning
confidence: 99%
“…For example, cholinesterase is a key enzyme in the management of Alzheimer’s disease, which hydrolyzing acetylcholine in the synaptic gap. At this point, the inhibition of cholinesterase could increase the level of acetylcholine in the synaptic cleft and these effects may help to improve cognitive dysfunctions in Alzheimer patients [ 38 ]. In another example, the blood glucose level in diabetes mellitus patients was controlled by the inhibition of amylase and glucosidase, which are the main clinically relevant carbohydrate-hydrolyzing enzymes [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Hence, several compounds are synthetically produced as enzyme inhibitors in the pharmaceutical industry. However, several studies have reported that synthetic compounds have unpleasant side effects [ 47 , 48 ]. Thus, enzyme inhibitors from natural sources are needed to replace these synthetic ones.…”
Section: Discussionmentioning
confidence: 99%